Literature DB >> 11137994

Dominant effector genetics in mammalian cells.

X Xu1, C Leo, Y Jang, E Chan, D Padilla, B C Huang, T Lin, T Gururaja, Y Hitoshi, J B Lorens, D C Anderson, B Sikic, Y Luo, D G Payan, G P Nolan.   

Abstract

We have expressed libraries of peptides in mammalian cells to select for trans-dominant effects on intracellular signaling systems. As an example-and to reveal pharmacologically relevant points in pathways that lead to Taxol resistance-we selected for peptide motifs that confer resistance to Taxol-induced cell death. Of several peptides selected, one, termed RGP8.5, was linked to upregulation of expression of the gene ABCB1 (also known as MDR1, for multiple drug resistance) in HeLa cells. Our data indicate that trans-dominant effector peptides can point to potential mechanisms by which signaling systems operate. Such tools may be useful in functional genomic analysis of signaling pathways in mammalian disease processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11137994     DOI: 10.1038/83717

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  19 in total

1.  Oligonucleotide-directed site-specific integration of high complexity libraries into ssDNA templates.

Authors:  M B Hale; G P Nolan; R Wolkowicz
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

2.  Ligand-directed profiling of organelles with internalizing phage libraries.

Authors:  Andrey S Dobroff; Roberto Rangel; Liliana Guzman-Roja; Carolina C Salmeron; Juri G Gelovani; Richard L Sidman; Cristian G Bologa; Tudor I Oprea; C Jeffrey Brinker; Renata Pasqualini; Wadih Arap
Journal:  Curr Protoc Protein Sci       Date:  2015-02-02

3.  Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study.

Authors:  Yi-Jun Wang; Yun-Kai Zhang; Guan-Nan Zhang; Sweilem B Al Rihani; Meng-Ning Wei; Pranav Gupta; Xiao-Yu Zhang; Suneet Shukla; Suresh V Ambudkar; Amal Kaddoumi; Zhi Shi; Zhe-Sheng Chen
Journal:  Cancer Lett       Date:  2017-03-14       Impact factor: 8.679

4.  Txr1: a transcriptional regulator of thrombospondin-1 that modulates cellular sensitivity to taxanes.

Authors:  Chih-Jian Lih; Wensheng Wei; Stanley N Cohen
Journal:  Genes Dev       Date:  2006-07-17       Impact factor: 11.361

5.  Protein kinase A type II-α regulatory subunit regulates the response of prostate cancer cells to taxane treatment.

Authors:  Evan R Zynda; Vitaliy Matveev; Michael Makhanov; Alexander Chenchik; Eugene S Kandel
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  A lentiviral cDNA library employing lambda recombination used to clone an inhibitor of human immunodeficiency virus type 1-induced cell death.

Authors:  Yuji Kawano; Takeshi Yoshida; Kuniko Hieda; Jun Aoki; Hiroyuki Miyoshi; Yoshio Koyanagi
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  Selection of peptides interfering with a ribosomal frameshift in the human immunodeficiency virus type 1.

Authors:  Dominic Dulude; Gabriel Théberge-Julien; Léa Brakier-Gingras; Nikolaus Heveker
Journal:  RNA       Date:  2008-03-26       Impact factor: 4.942

8.  Induction and characterization of taxol-resistance phenotypes with a transiently expressed artificial transcriptional activator library.

Authors:  Dong-ki Lee; Yong Ha Kim; Jin-Soo Kim; Wongi Seol
Journal:  Nucleic Acids Res       Date:  2004-08-10       Impact factor: 16.971

9.  Targeting mammalian organelles with internalizing phage (iPhage) libraries.

Authors:  Roberto Rangel; Andrey S Dobroff; Liliana Guzman-Rojas; Carolina C Salmeron; Juri G Gelovani; Richard L Sidman; Renata Pasqualini; Wadih Arap
Journal:  Nat Protoc       Date:  2013-09-12       Impact factor: 13.491

10.  A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design.

Authors:  E Warbrick
Journal:  Oncogene       Date:  2006-05-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.